Re: Risk of miscarriage following amniocentesis and chorionic villus sampling

Ultrasound in Obstetrics and Gynecology

Volumn 45, Issue 6, 2015, Pages 755-

  Ghidini, A ^a  

^a INOVA ALEXANDRIA HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABORTION, SPONTANEOUS; ADVERSE EFFECTS; AMNIOCENTESIS; CHORION VILLUS SAMPLING; FEMALE; HUMAN; PREGNANCY; PRENATAL DIAGNOSIS;

ABORTION, SPONTANEOUS; AMNIOCENTESIS; CHORIONIC VILLI SAMPLING; FEMALE; HUMANS; PREGNANCY; PRENATAL DIAGNOSIS;

EID: 84930339553     PISSN: 09607692     EISSN: 14690705     Source Type: Journal    
DOI: 10.1002/uog.14850     Document Type: Letter

References (5)

1. Akolekar R, Beta J, Picciarelli G, Ogilvie C, D'Antonio F,. Procedure-related risk of miscarriage following amniocentesis and chorionic villus sampling: a systematic review and meta-analysis. Ultrasound Obstet Gynecol 2015; 45: 16-26.
2. Won RH, Currier RJ, Lorey F, Towner DR,. The timing of demise in fetuses with trisomy 21 and trisomy 18. Prenat Diagn 2005; 25: 608-611.
3. Muller F, Thibaud D, Poloce F, Gelineau MC, Bernard M, Brochet C, Millet C, Réal JY, Dommergues M,. Risk of amniocentesis in women screened positive for Down syndrome with second trimester maternal serum markers. Prenat Diagn 2002; 22: 1036-1039.
4. Kong CW, Leung TN, Leung TY, Chan LW, Sahota DS, Fung TY, Lau TK,. Risk factors for procedure-related fetal losses after mid-trimester genetic amniocentesis. Prenat Diagn 2006; 26: 925-930.
5. Pitukkijronnakorn S, Promsonthi P, Panburana P, Udomsubpayakul U, Chittacharoen A,. Fetal loss associated with second trimester amniocentesis. Arch Gynecol Obstet 2011; 284: 793-797.